Endocrine Function Diagnostics Market, Report By Test Type (Thyroid Function Tests, Diabetes Tests, Adrenal Function Tests, and Reproductive Hormone Tests), By Technology, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4701
|
Published Date
February 2026
|
Pages
310
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Endocrine Function Diagnostics Market size was valued at US$13,120.10 Million in 2024, expanding at a CAGR of 7.97% from 2025 to 2032.
The global endocrine function diagnostics market is experiencing steady growth, driven by the rising prevalence of hormonal disorders, the increasing incidence of diabetes and thyroid diseases, and growing demand for early and accurate diagnostic solutions. Endocrine diagnostics are critical for assessing hormone levels and gland function, supporting disease diagnosis, treatment planning, and long-term patient monitoring. Technological advancements in immunoassays, mass spectrometry, and automated analyzers are enhancing test precision, throughput, and reliability, while expanding diagnostic infrastructure is improving access across both developed and emerging economies. This growth is reinforced by government-reported disease burdens; for instance, the World Health Organization (WHO) estimates that more than 422 million people globally are living with diabetes, and thyroid and other endocrine disorders continue to affect hundreds of millions worldwide, underscoring the increasing need for robust endocrine diagnostic services within national healthcare systems.
Endocrine Function Diagnostics Market- Market Dynamics
Increasing Incidence of Hormonal and Metabolic Disorders
The rising global prevalence of diabetes, thyroid disorders, adrenal dysfunction, and reproductive hormone imbalances is driving increased demand for endocrine function diagnostics, as effective management of these conditions relies on regular hormone testing. Growing awareness of preventive healthcare and the importance of early disease detection is further boosting the adoption of these diagnostic tests. Simultaneously, innovations in automated diagnostic platforms, high-sensitivity assays, and portable testing solutions are enhancing accessibility and reducing turnaround times. For example, in January 2025, Eli Health introduced Hormometer, a saliva-based hormone analysis device that integrates with smartphones to provide portable diagnostic testing. The platform transforms mobile devices into personal hormone analysers, initially measuring cortisol and progesterone, and delivers results in approximately 20 minutes—demonstrating the increasing trend toward decentralized, convenient, and user-friendly endocrine diagnostics.
Endocrine Function Diagnostics Market- Segmentation Analysis:
The Global Endocrine Function Diagnostics Market is segmented on the basis of Test Type, Technology, Application, and Region.
Based on test type, the market is segmented into thyroid function tests, diabetes tests, adrenal function tests, reproductive hormone tests, and others. Among these, thyroid and diabetes tests account for a significant share due to the high global prevalence of thyroid disorders and diabetes. The World Health Organization reports that over 500 million adults worldwide are affected by diabetes, while thyroid disorders impact more than 200 million people globally. Rising incidence of lifestyle-related disorders, coupled with increased public awareness of the benefits of early diagnosis, has further driven testing demand. These tests are also routinely included in preventive health check-ups and national screening programs, particularly in developed and emerging economies, supporting their substantial and sustained market share.
By technology, the market is categorized into immunoassays, tandem mass spectrometry (LC-MS/MS), enzyme-linked assays, and others. Immunoassays dominate the segment owing to their wide adoption, high sensitivity, automation compatibility, and cost-effectiveness, making them ideal for routine clinical use. Their ability to process large volumes of patient samples efficiently has made them central to hospital laboratories and diagnostic chains worldwide. Governments have actively promoted the use of standardized, high-throughput immunoassay platforms in public health laboratories, with national health agencies reporting that over 70% of routine endocrine and metabolic testing now relies on automated immunoassay systems, reflecting both policy support and technology adoption in large-scale diagnostic settings. Continuous innovation and the availability of validated kits further strengthen the position of immunoassays in the market.
In terms of application, the market is divided into hospitals, diagnostic laboratories, research institutes, and other end users. Diagnostic laboratories hold the largest market share due to their ability to handle high test volumes and provide centralized, efficient testing services. The expansion of diagnostic chains and the growing trend of outsourcing laboratory services from hospitals and clinics have reinforced their dominance. Many governments have encouraged centralized laboratory networks to improve testing efficiency and ensure uniform quality standards, with public health reports indicating that centralized labs conduct more than 60% of endocrine and metabolic diagnostic tests in urban regions, highlighting the critical role of these facilities in national healthcare infrastructure. Hospitals and research institutes remain important end users, but diagnostic laboratories continue to drive the majority of market activity.
Endocrine Function Diagnostics Market- Geographical Insights
North America dominates the endocrine function diagnostics market, fueled by advanced healthcare infrastructure, high awareness of hormonal disorders, and widespread adoption of automated diagnostic technologies. Europe follows closely, benefiting from well-established laboratory networks and comprehensive preventive screening programs. The Asia-Pacific region is projected to register the fastest growth, driven by rising healthcare expenditure, increasing prevalence of diabetes and thyroid disorders, and expanding diagnostic infrastructure in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are witnessing steady growth, supported by improving healthcare access and ongoing modernization of diagnostic facilities. Government initiatives are also boosting market growth globally; for example, in 2024, the U.S. National Institutes of Health (NIH) allocated over USD 2.5 billion toward diabetes and endocrine research, while China’s National Health Commission launched a nationwide endocrine disorder screening program targeting early detection and prevention in high-risk populations.
Endocrine Function Diagnostics Market- Country Insights
The United States leads the endocrine function diagnostics market, driven by high testing volumes, favorable reimbursement policies, and the presence of established diagnostic companies that foster innovation and efficiency. This well-developed healthcare ecosystem ensures broad access to advanced diagnostic technologies, enabling timely detection and management of endocrine disorders. In Europe, countries such as Germany, the UK, and France play a key role in market growth, supported by strong public healthcare systems and proactive early screening programs that emphasize preventive care. The Asia-Pacific region, particularly China and India, is emerging as a high-growth market due to large patient populations, rising awareness of endocrine disorders, and rapid expansion of hospital and laboratory infrastructure, which improves accessibility and availability of diagnostic services. For example, in 2024, the Chinese National Health Commission launched the “Endocrine Health Screening Initiative,” targeting early detection of diabetes and thyroid disorders nationwide, while India’s Ministry of Health and Family Welfare issued guidelines in 2025 promoting routine endocrine testing under national health programs. As healthcare systems continue to advance in these regions, they are expected to further strengthen the global endocrine diagnostics landscape, enhancing patient outcomes and overall quality of care.
Endocrine Function Diagnostics Market- Competitive Landscape:
The endocrine function diagnostics market is moderately competitive, featuring a mix of global and regional players such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, bioMérieux, Sysmex Corporation, DiaSorin S.p.A., Mindray Medical International, and Ortho Clinical Diagnostics. These companies are increasingly focusing on assay innovation, automation, and expanding their test portfolios to address growing healthcare demands. Significant investments are being directed toward high-throughput platforms, advanced immunoassays, and integrated diagnostic solutions, which improve both accuracy and laboratory workflow efficiency.
Strategic collaborations and product launches play a critical role in strengthening market positions. Geographic expansion is also a key focus, enabling companies to reach new markets and enhance access to endocrine diagnostics. For instance, in September 2024, Trinity Biotech acquired Metabolomics Diagnostics to strengthen its maternal health portfolio. The acquisition provides access to advanced mass spectrometry and machine learning capabilities, supporting the development of PrePsia, an early-stage preeclampsia risk test. This move reflects a strategic push into biomarker-based, advanced diagnostic solutions. The market landscape continues to evolve, driven by technological advancements and a focus on improving patient care, which are essential for effective monitoring and management of endocrine disorders across diverse healthcare settings.
Recent Developments:
- In January 2025, Eli Health launched Hormometer, a device for saliva-based hormone analysis. The system leverages smartphone technology to enable portable diagnostic testing, effectively turning smartphones into personal analysers.
- In April 2023, Eli Health raised USD 3.6 million to advance its saliva-based hormone monitoring technology. The company is initially focusing on menopause, fertility, and general health management, with long-term plans to expand into contraception and broader endocrine disease management. This growth follows the successful completion of critical clinical trials and regulatory approvals.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- bioMérieux
- Sysmex Corporation
- DiaSorin S.p.A.
- Mindray Medical International
- Ortho Clinical Diagnostics
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TEST TYPE - MARKET ANALYSIS, 2019 - 2032
- Thyroid Function Tests
- Diabetes Tests
- Adrenal Function Tests
- Reproductive Hormone Tests
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032
- Immunoassays
- Tandem Mass Spectrometry (LC-MS/MS)
- Enzyme-linked Assays
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Endocrine Function Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Endocrine Function Diagnostics Market Snippet by Test Type
2.1.2. Endocrine Function Diagnostics Market Snippet by Technology
2.1.3. Endocrine Function Diagnostics Market Snippet by Application
2.1.4. Endocrine Function Diagnostics Market Snippet by Country
2.1.5. Endocrine Function Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Endocrine Function Diagnostics Key Market Trends
3.1. Endocrine Function Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Endocrine Function Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Endocrine Function Diagnostics Market Opportunities
3.4. Endocrine Function Diagnostics Market Future Trends
4. Endocrine Function Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Endocrine Function Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Endocrine Function Diagnostics Market Landscape
6.1. Endocrine Function Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Endocrine Function Diagnostics Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2024&2032 (%)
7.1.2. Thyroid Function Tests
7.1.3. Diabetes Tests
7.1.4. Adrenal Function Tests
7.1.5. Reproductive Hormone Tests
7.1.6. Others
8. Endocrine Function Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
8.1.2. Immunoassays
8.1.3. Tandem Mass Spectrometry (LC-MS/MS)
8.1.4. Enzyme-linked Assays
8.1.5. Others
9. Endocrine Function Diagnostics Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Laboratories
9.1.4. Research Institutes
9.1.5. Others
10. Endocrine Function Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Endocrine Function Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Endocrine Function Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Endocrine Function Diagnostics Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Endocrine Function Diagnostics Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Endocrine Function DiagnosticsKey Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Endocrine Function Diagnostics Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1.1.
11.2.2. Roche Diagnostics
11.2.3. Siemens Healthineers
11.2.4. Danaher Corporation
11.2.5. Thermo Fisher Scientific
11.2.6. bioMérieux
11.2.7. Sysmex Corporation
11.2.8. DiaSorin S.p.A.
11.2.9. Mindray Medical International
11.2.10. Ortho Clinical Diagnostics
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- bioMérieux
- Sysmex Corporation
- DiaSorin S.p.A.
- Mindray Medical International
- Ortho Clinical Diagnostics
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TEST TYPE - MARKET ANALYSIS, 2019 - 2032
- Thyroid Function Tests
- Diabetes Tests
- Adrenal Function Tests
- Reproductive Hormone Tests
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032
- Immunoassays
- Tandem Mass Spectrometry (LC-MS/MS)
- Enzyme-linked Assays
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
